Lymphoma

Cell reprogramming to cure leukaemia and lymphoma

Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukaemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce ...

Apr 03, 2013
popularity 5 / 5 (4) | comments 0

High-dose Vorinostat effective at treating relapsed lymphomas

Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease. Reporting the results of a first-of-its-kind ...

Feb 04, 2013
popularity not rated yet | comments 0

Latest Spotlight News